BIOMAT Database Logo BIOMAT Database Logo

Special report: cardiovascular disease in women. Special writing group. 1994

E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
February 1993, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.
October 1997, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Cardiovascular Disease Management in Minority Women: Special Considerations.
March 2019, Critical care nursing clinics of North America,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology.
May 2002, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing Group.
March 2005, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing Group.
March 2005, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications.
May 2002, Circulation,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Special Considerations in the Prevention of Cardiovascular Disease in Women.
February 2022, Arquivos brasileiros de cardiologia,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Cardiovascular risk in special populations: hypertensive disease in women. Introduction.
May 2002, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
E Eaker, and J H Chesebro, and F M Sacks, and N K Wenger, and J P Whisnant, and M Winston
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Basic Science Writing Group.
March 2005, Circulation,
Copied contents to your clipboard!